Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Respivert LtdfiledCriticalRespivert Ltd
Publication of CR20150391ApublicationCriticalpatent/CR20150391A/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
La presente invención se refiere, inter alia, a un compuesto de la fórmula (I), y a composiciones que comprenden el compuesto, y al uso de los compuestos y composiciones de los compuestos en el tratamiento, por ejemplo, en el tratamiento de enfermedades inflamatorias, en particular, enfermedades inflamatorias respiratorias. La invención además se extiende a métodos de elaboración de dichos compuestos.The present invention relates, inter alia, to a compound of the formula (I), and to compositions comprising the compound, and to the use of the compounds and compositions of the compounds in the treatment, for example, in the treatment of inflammatory diseases. , in particular, inflammatory respiratory diseases. The invention further extends to methods of making said compounds.
CR20150391A2013-03-152015-07-27
DERIVATIVES 2 - ((4-AMINO-3- (3-FLUORO-5-HIDROXIFENILO) -1H-PIRAZOLO [3,4-D] PIRIMIDIN-1-IL) METHYL) -3- (2- (TRIFLUORO-METHYL) BENCILO) QUINAZOLIN-4 (3H) -ONA AND ITS USE AS QUINASE-3 PHOSFOINOSITIDA INHIBITORS
CR20150391A
(en)
DERIVATIVES OF 2 - ((4-AMINO-3- (3-FLUORO-5-HYDROXYPHENIL) -1H-PIRAZOLO [3,4-D] PYRIMIDIN-1-IL) METHYL) -3- (2- (TRIFLUOROMETHYL) BENZYL ) QUINAZOLINE-4 (3H) -ONE AND ITS USE AS INHIBITORS OF PHOSPHOINOSITIDE 3-KINASES
Compounds derived from (phenyl or pyridin) -ethynyl- (pyridin or pyrimidin) substituted; pharmaceutical composition comprising them; process of preparing this; and its use in the treatment of schizophrenia or cognitive diseases.